LS9 Inc., the Renewable Petroleum Company(TM), has raised secured $5 million in Series A funding from Flagship Ventures and Khosla Ventures, two top-tier early-stage investment firms, and has established its Scientific Advisory Board (SAB). The funding and SAB appointments will significantly accelerate LS9’s plans to pursue industrial applications of synthetic biology to produce proprietary biofuels and industrial chemicals.
“LS9 is a pioneer in extending the promise of biofuels beyond ethanol and biodiesel,” said Noubar Afeyan, Managing Partner and CEO of Flagship Ventures. “By applying new biological engineering tools towards meeting the growing market needs for alternative energy, the company is already creating significant value with its IP as well as its proprietary new products under development.”
“New technologies developed at companies like LS9 will transform the energy world as fundamentally as Internet technologies have changed the telecommunications industry. We’re excited to work with LS9 to bring the next generation of biofuels to market,” stated Vinod Khosla, Managing Partner of Khosla Ventures.
About LS9
LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held biotechnology company. LS9 is pursuing industrial applications of synthetic biology to produce biofuels that are compatible with existing fuel distribution and consumer infrastructure. Based on an enabling technology portfolio, LS9 was founded in 2005 by leading scientists along with venture capital firms Flagship Ventures and Khosla Ventures. LS9 is headquartered in San Carlos, California, in the heart of Silicon Valley.
Loading...